Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TNM002 in Healthy Adults

NCT04629131 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Subjects

Interventions

BIOLOGICAL: TNM002 Dosage 1 (10 μg/kg)
BIOLOGICAL: Placebo
BIOLOGICAL: TNM002 Dosage 2 (35 μg/kg)
BIOLOGICAL: Placebo
BIOLOGICAL: TNM002 Dosage 3 (100 μg/kg)
BIOLOGICAL: Placebo
BIOLOGICAL: TNM002 Dosage 4 (250 μg/kg)
BIOLOGICAL: Placebo

Sponsor

Zhuhai Trinomab Pharmaceutical Co., Ltd.

Collaborators

[object Object]